ROS-Mediated Apoptosis and Anticancer Effect Achieved by Artesunate and Auxiliary Fe(II) Released from Ferriferous Oxide-Containing Recombinant Apoferritin.


Journal

Advanced healthcare materials
ISSN: 2192-2659
Titre abrégé: Adv Healthc Mater
Pays: Germany
ID NLM: 101581613

Informations de publication

Date de publication:
12 2019
Historique:
received: 11 07 2019
revised: 23 10 2019
pubmed: 9 11 2019
medline: 1 9 2020
entrez: 9 11 2019
Statut: ppublish

Résumé

Reactive oxygen species (ROS)-mediated apoptosis is considered a crucial therapeutic mechanisms for artesunate (AS). As an Fe(II)-dependent drug, the anticancer effect of AS is often limited due to insufficient Fe(II) concentration in targeted cells. To overcome this problem, a recombinant apoferritin nanocarrier containing ferriferous oxide (M-HFn) is constructed to produce auxiliary exogenous Fe(II) when delivering AS to cancer cells. Here, the newly fabricated AS-loaded M-HFn nanoparticles (M-HFn@AS NPs) can significantly improve the tumor-specific targeting and intracellular uptake efficiency of AS in human cervical carcinoma cells. After being captured in the acidic cavity of endosomes, M-HFn@AS NPs can simultaneously release Fe(II) and allow AS to activate satisfactory ROS-mediated apoptosis. Furthermore, in vivo studies demonstrate that M-HFn@AS NPs can selectively accumulate in tumors to efficiently inhibit tumor growth. Thus, M-HFn@AS NPs are a promising system to enhance the therapeutic effect of Fe(II)-dependent drugs.

Identifiants

pubmed: 31701665
doi: 10.1002/adhm.201900911
doi:

Substances chimiques

Reactive Oxygen Species 0
Artesunate 60W3249T9M
Apoferritins 9013-31-4
Iron E1UOL152H7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1900911

Subventions

Organisme : National Natural Science Foundation of China
ID : 51472115
Pays : International
Organisme : Top-notch Academic Programs Project of Jiangsu Higher Education Institutions
ID : PPZY2015B164
Pays : International
Organisme : China Pharmaceutical University
ID : CPU2018GY40
Pays : International
Organisme : Jiangsu Provincial Graduate Research Innovation and Practice Project
ID : KYCX18_0760
Pays : International

Informations de copyright

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

L. Liu, Y. Liu, L. Ma, F. Mao, A. Jiang, D. Liu, L. Wang, Q. Jia, J. Zhou, ACS Appl. Mater. Interfaces 2018, 10, 6155.
a) E. Culakova, R. Thota, M. S. Poniewierski, N. M. Kuderer, A. F. Wogu, D. C. Dale, J. Crawford, G. H. Lyman, Cancer Med.. 2014, 3, 434;
b) M. Tan, W. Liu, F. Liu, W. Zhang, H. Gao, J. Cheng, Y. Chen, Z. Wang, Y. Cao, H. Ran, Theranostics 2019, 9, 961;
c) A. M. Florea, D. Busselberg, Cancers 2011, 3, 1351.
a) H. Wang, Q. Mu, R. Revia, K. Wang, X. Zhou, P. J. Pauzauskie, S. Zhou, M. Zhang, Adv. Healthcare Mater. 2017, 6, 1601080;
b) D. D. Wang, J. J. Zhou, R. H. Chen, R. H. Ship, C. L. Wang, J. Lu, G. Z. Zhao, G. L. Xia, S. Zhou, Z. B. Liu, H. B. Wang, Z. Guo, Q. W. Chen, Chem. Mater. 2017, 29, 3477.
a) S. Gao, X. Cheng, J. Li, OncoTargets Ther. 2019, 12, 1841;
b) A. L. Greenshields, W. Fernando, D. W. Hoskin, Exp. Mol. Pathol. 2019, 107, 10.
L. Hou, X. N. Shan, L. S. Hao, Q. H. Feng, Z. Z. Zhang, Acta Biomater. 2017, 54, 307.
P. M. O'Neill, V. E. Barton, S. A. Ward, Molecules 2010, 15, 1705.
H. Zhang, L. Hou, X. Jiao, Y. Ji, X. Zhu, Z. Zhang, Biomaterials 2015, 37, 353.
A. V. Bazhin, P. P. Philippov, S. Karakhanova, Oxid. Med. Cell. Longevity 2016, 2016, 1.
a) H. Zhang, Q. Chen, X. Zhang, X. Zhu, J. Chen, H. Zhang, L. Hou, Z. Zhang, ACS Appl. Mater. Interfaces 2016, 8, 33484;
b) H. Zhang, H. Zhang, X. Zhu, X. Zhang, Q. Chen, J. Chen, L. Hou, Z. Zhang, Oncotarget 2017, 8, 58738.
a) S. Recalcati, E. Gammella, P. Buratti, G. Cairo, IUBMB Life 2017, 69, 389;
b) X. Huang, Mutat. Res., Fundam. Mol. Mech. Mutagen. 2003, 533, 153;
c) Z. Shoja, M. Chenari, A. Jafarpour, S. Jalilvand, Rev. Med. Virol. 2019, 29, e2045.
H. Zhang, Y. Ji, Q. Chen, X. Jiao, L. Hou, X. Zhu, Z. Zhang, J. Drug Targeting 2015, 23, 552.
P. T. Gomme, K. B. McCann, J. Bertolini, Drug Discovery Today 2005, 10, 267.
Y. Lei, Y. Hamada, J. Li, L. Cong, N. Wang, Y. Li, W. Zheng, X. Jiang, J. Controlled Release 2016, 232, 131.
a) L. Minmin, F. Kelong, Z. Meng, D. Demin, Z. Jiyan, Y. Dongling, F. Jing, Y. Xiyun, Proc. Natl. Acad. Sci. USA 2014, 111, 14900;
b) L. Pandolfi, M. Bellini, R. Vanna, C. Morasso, A. Zago, S. Carcano, S. Avvakumova, J. A. Bertolini, M. A. Rizzuto, M. Colombo, D. Prosperi, Biomacromolecules 2017, 18, 3318;
c) K. Fan, X. Jia, M. Zhou, K. Wang, J. Conde, J. He, J. Tian, X. Yan, ACS Nano 2018, 12, 4105.
A. I. Kuruppu, L. Zhang, H. Collins, L. Turyanska, N. R. Thomas, T. D. Bradshaw, Adv. Healthcare Mater. 2015, 4, 2816.
L. Li, M. Munoz-Culla, U. Carmona, M. P. Lopez, F. Yang, C. Trigueros, D. Otaegui, L. Zhang, M. Knez, Biomaterials 2016, 98, 143.
F. Kelong, C. Changqian, P. Yongxin, L. Di, Y. Dongling, F. Jing, S. Lina, L. Minmin, Y. Xiyun, Nat. Nanotechnol. 2012, 7, 459.
C. Cao, L. Tian, Q. Liu, W. Liu, G. Chen, Y. Pan, J. Geophys. Res.: Solid Earth 2010, 115, B07103.
M. Aihui, T. Zhiwen, W. Hong, W. Jun, L. Yuehe, Small 2010, 5, 1706.
T. J. Todd, Z. Zhen, J. Xie, Nanomedicine 2013, 8, 1555.
E. J. Lee, N. K. Lee, I. S. Kim, Adv. Drug Delivery Rev. 2016, 106, 157.
B. Wang, H. Zhang, J. An, Y. Zhang, L. Sun, Y. Jin, J. Shi, M. Li, H. Zhang, Z. Zhang, Nano Lett. 2019, 19, 3505.
Y. Ding, J. Wan, Z. Zhang, F. Wang, C. Wang, ACS Appl. Mater. Interfaces 2018, 10, 4439.
J. Chen, Z. Guo, H.-B. Wang, J.-J. Zhou, W.-J. Zhang, Q.-W. Chen, Biomaterials 2014, 35, 6498.
T. Liu, W. Liu, M. Zhang, W. Yu, F. Gao, C. Li, S. B. Wang, J. Feng, X. Z. Zhang, ACS Nano 2018, 12, 12181.
T. R. Daniels, E. Bernabeu, J. A. Rodriguez, S. Patel, M. Kozman, D. A. Chiappetta, E. Holler, J. Y. Ljubimova, G. Helguera, M. L. Penichet, Biochim. Biophys. Acta, Gen. Subj. 2012, 1820, 291.
J. Yue, S. Liu, R. Wang, X. Hu, Z. Xie, Y. Huang, X. Jing, Mol. Pharm. 2012, 9, 1919.
H. Zhang, Y. Zhao, M. Yu, Z. Zhao, P. Liu, H. Cheng, Y. Ji, Y. Jin, B. Sun, J. Zhou, J. Controlled Release 2019, 296, 14.
Z. Chen, L. Xing, Q. Fan, A. G. Cheetham, R. Lin, B. Holt, L. Chen, Y. Xiao, H. Cui, Theranostics 2017, 7, 2003.
J. Yujie, X. Yanyu, X. Liu, H. Jiayu, Q. Chen, L. Weidong, W. Li, C. Rui, W. Jingjing, H. Rongfeng, Adv. Sci. 2018, 5, 1700867.
C. Huang, Z. Zhang, Q. Guo, L. Zhang, F. Fan, Y. Qin, H. Wang, S. Zhou, W. Ou-Yang, H. Sun, X. Leng, X. Pan, D. Kong, L. Zhang, D. Zhu, Adv. Healthcare Mater. 2019, 8, 1900840.
C. Q. Luo, Y. X. Zhou, T. J. Zhou, L. Xing, P. F. Cui, M. Sun, L. Jin, N. Lu, H. L. Jiang, J. Controlled Release 2018, 274, 56.
Z. Fei, W. Han, K. Patricilia, C. Xuemei, L. Qiu-Ling, L. Tao, Oncol. Rep. 2013, 30, 1473.
E. Falvo, E. Tremante, A. Arcovito, M. Papi, N. Elad, A. Boffi, V. Morea, G. Conti, G. Toffoli, G. Fracasso, Biomacromolecules 2016, 17, 514.
G. Song, C. Yu, Y. Chen, L. Chao, Y. Xuan, G. Yang, Y. Kai, C. Liang, Z. Qiao, L. Zhuang, Adv. Funct. Mater. 2016, 26. 955.
a) H. Maeda, Adv. Drug Delivery Rev. 2015, 91, 3;
b) T. Ojha, V. Pathak, Y. Shi, W. E. Hennink, C. T. W. Moonen, G. Storm, F. Kiessling, T. Lammers, Adv. Drug Delivery Rev. 2017, 119, 44;
c) B. Theek, M. Baues, F. Gremse, R. Pola, M. Pechar, I. Negwer, K. Koynov, B. Weber, M. Barz, W. Jahnen-Dechent, G. Storm, F. Kiessling, T. Lammers, J. Controlled Release 2018, 282, 25.
a) L. Li, C. J. Fang, J. C. Ryan, E. C. Niemi, J. A. Lebron, P. J. Bjorkman, H. Arase, F. M. Torti, S. V. Torti, M. C. Nakamura, W. E. Seaman, Proc. Natl. Acad. Sci. USA 2010, 107, 3505;
b) H. Li, Z. M. Qian, Med. Res. Rev. 2002, 22, 225.
a) X. Lin, J. Xie, G. Niu, F. Zhang, H. Gao, M. Yang, Q. Quan, M. A. Aronova, G. Zhang, S. Lee, Nano Lett. 2011, 11, 814;
b) H. Peng, R. Pengfei, J. Albert, Y. Xuefeng, Z. M. Gu, L. Jing, H. Hao, W. Zhe, Y. Xuyi, L. Wanwan, Adv. Mater. 2015, 26, 6401.
a) P. C. H. Li, L. Elena, W. P. Roos, M. Z. Zdzienicka, K. Bernd, E. Thomas, Cancer Res. 2008, 68, 4347;
b) Y. Yang, X. Zhang, X. Wang, X. Zhao, T. Ren, F. Wang, B. Yu, Int. J. Pharm. 2014, 467, 113;
c) I. Leto, M. Coronnello, C. Righeschi, M. C. Bergonzi, E. Mini, A. R. Bilia, ChemMedChem 2016, 11, 1745.
K. Shao, N. Ding, S. Huang, S. Ren, Y. Zhang, Y. Kuang, Y. Guo, H. Ma, S. An, Y. Li, C. Jiang, ACS Nano 2014, 8, 1191.
Y. Zhang, F. Wang, M. Li, Z. Yu, R. Qi, J. Ding, Z. Zhang, X. Chen, Adv. Sci. 2018, 5, 1700821.
Z. Zhang, W. Hong, T. Tao, L. Jie, Y. Li, Adv. Funct. Mater. 2018, 28, 1801840.
W. Zou, X. Liu, D. Chen, J. Wang, X. Zhao, J. Li, L. Ji, Z. Hua, Prep. Biochem. Biotechnol. 2016, 46, 833.
U. Masaki, M. L. Flenniken, A. Mark, D. A. Willits, B. E. Crowley, B. Susan, A. F. Willis, J. Larissa, J. Mark, M. J. Young, J. Am. Chem. Soc. 2006, 128, 16626.

Auteurs

Peng Ji (P)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Haiqin Huang (H)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Shirui Yuan (S)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Le Wang (L)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Siqi Wang (S)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Yiwei Chen (Y)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Na Feng (N)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Hanitrarimalala Veroniaina (H)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Ziheng Wu (Z)

Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, 3800, Australia.

Zhenghong Wu (Z)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Xiaole Qi (X)

College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH